Garlance Pharmaceuticals Private Limited
About Garlance Pharmaceuticals Private Limited
Data last updated:
Garlance Pharmaceuticals Private Limited was a private limited company based in New Delhi, Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 24 July 2014.
The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2014PTC269352. The company has 1 GST registration on record, which is no longer active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Vikas Sharma and Dhruv Sharma.
Its last annual general meeting (AGM) was held on 30 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at Wz 20A Shop No 2 Asalat Pur, New Delhi, Delhi, India – 110058.
As per the financials filed for FY 2017, the company reported a revenue of ₹18.28 Lakh. For the same year it recorded a net profit of ₹19,609 (net margin 1.1%) and EBITDA of ₹2.98 Lakh (EBITDA margin 16.3%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressWz 20A Shop No 2 Asalat Pur, New Delhi, Delhi, India – 110058
- IndustryChemicals, Medicinal Chemical & Botanical Products, Chemical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Garlance Pharmaceuticals Private Limited FY 2020 filings available
Garlance Pharmaceuticals Private Limited reported revenue of ₹18.28 Lakh for FY 2017.
Financial Statement Summary of Garlance Pharmaceuticals Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | ₹18.28 Lakh | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹2.98 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹19,609 | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Garlance Pharmaceuticals Private Limited
| Metrics | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 16.3% | •••• | •••• |
| Net Profit Margin | 1.1% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Garlance Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Garlance Pharmaceuticals Private Limited
Garlance Pharmaceuticals Private Limited is audited by ANIL MANDIRATTA for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ANIL MANDIRATTA | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Garlance Pharmaceuticals Private Limited
Garlance Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vikas Sharma | Director | 24 Jul 2014 | 12 Years 2 Months | As last reported |
| Dhruv Sharma | Director | 23 Aug 2014 | 12 Years 1 Months | As last reported |
Ownership and Shareholding of Garlance Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Garlance Pharmaceuticals Private Limited
Garlance Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Garlance Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Garlance Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Garlance Pharmaceuticals Private Limited
Garlance Pharmaceuticals Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Dhruv Sharma was appointed as Director on 23 Aug 2014.
Credit Ratings, Litigation & Regulatory Alerts for Garlance Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Garlance Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Garlance Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Garlance Pharmaceuticals Private Limited
Garlance Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Garlance Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Garlance Pharmaceuticals Private Limited
Garlance Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Garlance Pharmaceuticals was a private limited company based in New Delhi, Delhi, India. The company worked in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 24 July 2014 and is registered under CIN U51909DL2014PTC269352. The company has been struck off by the Registrar of Companies and is no longer operational.
Garlance Pharmaceuticals had 2 directors:
- Vikas Sharma - Director
- Dhruv Sharma - Director
The CIN (Corporate Identification Number) of Garlance Pharmaceuticals is U51909DL2014PTC269352. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Garlance Pharmaceuticals is at Wz 20A Shop No 2 Asalat Pur, New Delhi, Delhi, India – 110058.
Garlance Pharmaceuticals was incorporated on 24 July 2014. It is registered with the Registrar of Companies, Delhi.
Garlance Pharmaceuticals reported revenue of ₹18.28 Lakh for FY 2017.
Garlance Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.
Garlance Pharmaceuticals reported a net profit of ₹19,609 (net margin 1.1%) and EBITDA of ₹2.98 Lakh (EBITDA margin 16.3%) for FY 2017, as per its filed financial statements.
No. Garlance Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.